265 related articles for article (PubMed ID: 26894921)
1. Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.
Berger GE; Smesny S; Schäfer MR; Milleit B; Langbein K; Hipler UC; Milleit C; Klier CM; Schlögelhofer M; Holub M; Holzer I; Berk M; McGorry PD; Sauer H; Amminger GP
PLoS One; 2016; 11(2):e0148429. PubMed ID: 26894921
[TBL] [Abstract][Full Text] [Related]
2. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
[TBL] [Abstract][Full Text] [Related]
3. Salivary cortisol in early psychosis: New findings and meta-analysis.
Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
[TBL] [Abstract][Full Text] [Related]
4. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
[TBL] [Abstract][Full Text] [Related]
5. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
[TBL] [Abstract][Full Text] [Related]
6. Niacin skin flush test: a research tool for studying schizophrenia.
Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
[TBL] [Abstract][Full Text] [Related]
8. Non-reduction in hippocampal volume is associated with higher risk of psychosis.
Phillips LJ; Velakoulis D; Pantelis C; Wood S; Yuen HP; Yung AR; Desmond P; Brewer W; McGorry PD
Schizophr Res; 2002 Dec; 58(2-3):145-58. PubMed ID: 12409154
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.
Smesny S; Milleit B; Hipler UC; Milleit C; Schäfer MR; Klier CM; Holub M; Holzer I; Berger GE; Otto M; Nenadic I; Berk M; McGorry PD; Sauer H; Amminger GP
Mol Psychiatry; 2014 Mar; 19(3):317-24. PubMed ID: 23478748
[TBL] [Abstract][Full Text] [Related]
10. Impairment of olfactory identification ability in ultra-high risk for psychosis and drug-naïve first episode psychosis.
Ouyang L; Ma X; Yuan L; Fan L; Liao A; Li D; Yang Z; Zhang Z; Liu W; Chen X; Li Z; He Y
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jul; 133():111035. PubMed ID: 38795823
[TBL] [Abstract][Full Text] [Related]
11. Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis.
Kim SW; Schäfer MR; Klier CM; Berk M; Rice S; Allott K; Bartholomeusz CF; Whittle SL; Pilioussis E; Pantelis C; McGorry PD; Amminger GP
Schizophr Res; 2014 Sep; 158(1-3):39-44. PubMed ID: 25066495
[TBL] [Abstract][Full Text] [Related]
12. Impaired mismatch negativity to frequency deviants in individuals at ultra-high risk for psychosis, and preliminary evidence for further impairment with transition to psychosis.
Lavoie S; Jack BN; Griffiths O; Ando A; Amminger P; Couroupis A; Jago A; Markulev C; McGorry PD; Nelson B; Polari A; Yuen HP; Whitford TJ
Schizophr Res; 2018 Jan; 191():95-100. PubMed ID: 29132815
[TBL] [Abstract][Full Text] [Related]
13. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
14. Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls.
Pawełczyk T; Trafalska E; Pawełczyk A; Kotlicka-Antczak M
Early Interv Psychiatry; 2017 Dec; 11(6):498-508. PubMed ID: 26279283
[TBL] [Abstract][Full Text] [Related]
15. Altered depth of the olfactory sulcus in ultra high-risk individuals and patients with psychotic disorders.
Takahashi T; Wood SJ; Yung AR; Nelson B; Lin A; Yücel M; Phillips LJ; Nakamura Y; Suzuki M; Brewer WJ; Proffitt TM; McGorry PD; Velakoulis D; Pantelis C
Schizophr Res; 2014 Mar; 153(1-3):18-24. PubMed ID: 24530137
[TBL] [Abstract][Full Text] [Related]
16. Increased PLA
Talib LL; Costa AC; Joaquim HPG; Pereira CAC; Van de Bilt MT; Loch AA; Gattaz WF
Eur Arch Psychiatry Clin Neurosci; 2021 Dec; 271(8):1593-1599. PubMed ID: 33677687
[TBL] [Abstract][Full Text] [Related]
17. EEG microstates as biomarker for psychosis in ultra-high-risk patients.
de Bock R; Mackintosh AJ; Maier F; Borgwardt S; Riecher-Rössler A; Andreou C
Transl Psychiatry; 2020 Aug; 10(1):300. PubMed ID: 32839449
[TBL] [Abstract][Full Text] [Related]
18. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
[TBL] [Abstract][Full Text] [Related]
19. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
[TBL] [Abstract][Full Text] [Related]
20. Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia.
Smesny S; Rosburg T; Riemann S; Baur K; Rudolph N; Berger G; Sauer H
Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):393-402. PubMed ID: 15885994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
